Guaifenesin Tablet, Extended Release
Product Images NDC 58602-811

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 58602-811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (1200 mg (20 Tablet Label))

Package Label-principal Display Panel (1200 mg (20 Tablet Label))
FDA Label Image

Package Label-principal Display Panel (1200 mg (20 Tablet Carton Label))

Package Label-principal Display Panel (1200 mg (20 Tablet Carton Label))
The text provided is a list of prescription medication brands and dosages. It includes expectorant Guaifenesin which is used to relieve chest congestion. There is no further information available on the usage or side effects of these medications.*
FDA Label Image

Package Label-principal Display Panel (1200 mg Blister Carton (14 (1 x 14) Tablets))

Package Label-principal Display Panel (1200 mg Blister Carton (14 (1 x 14) Tablets))

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.